Absci to Participate in the 41st Annual J.P. Morgan Healthcare Conference
29 December 2022 - 12:00AM
Absci Corporation (Nasdaq: ABSI), a generative AI drug creation
company, today announced the company will be participating in the
upcoming 41st Annual J.P. Morgan Healthcare Conference in San
Francisco, CA.
Absci management is scheduled to present on
Thursday, January 12th at 8:15 a.m. Pacific Time (11:15 a.m.
Eastern Time). Interested parties may access a live and archived
webcast of the presentation on the company’s investor relations
website at: investors.absci.com.
About Absci
Absci is the drug and target discovery company
harnessing deep learning AI and synthetic biology to expand the
therapeutic potential of proteins. We built our Integrated Drug
Creation™ platform to identify novel drug targets, discover optimal
biotherapeutic candidates, and generate the cell lines to
manufacture them in a single efficient process. Biotech and pharma
innovators partner with us to create the next generation of
protein-based drugs, including Bionic™ proteins containing
nonstandard amino acids, and other novel drug designs that may be
impossible to make with other technologies. Our goal is to enable
the development of better medicines by Translating Ideas into
Drugs™. For more information visit www.absci.com and follow us on
social media: Twitter: @Abscibio, LinkedIn: @absci, and subscribe
to our Absci YouTube channel.
Availability of Other Information about
Absci
Investors and others should note that we routinely
communicate with investors and the public using our website
(www.absci.com) and our investor relations website
(investors.absci.com), including without limitation, through the
posting of investor presentations, SEC filings, press releases,
public conference calls and webcasts on these websites, as well as
on Twitter, LinkedIn and YouTube. The information that we post on
these websites and social media outlets could be deemed to be
material information. As a result, investors, the media, and others
interested in Absci are encouraged to review this information on a
regular basis. The contents of our website and social media
postings, or any other website that may be accessed from our
website or social media postings, shall not be deemed incorporated
by reference in any filing under the Securities Act of 1933, as
amended.
Investor
Contactinvestors@absci.com
Media Contactpress@absci.com
AbSci (NASDAQ:ABSI)
Historical Stock Chart
From Mar 2024 to Apr 2024
AbSci (NASDAQ:ABSI)
Historical Stock Chart
From Apr 2023 to Apr 2024